Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000816141 | SCV000956634 | uncertain significance | Early myoclonic encephalopathy | 2023-09-25 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt JMJD1C protein function. ClinVar contains an entry for this variant (Variation ID: 659177). This variant has not been reported in the literature in individuals affected with JMJD1C-related conditions. This variant is present in population databases (rs770912020, gnomAD 0.02%). This sequence change replaces leucine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 362 of the JMJD1C protein (p.Leu362Arg). |
Ambry Genetics | RCV004028878 | SCV004889503 | uncertain significance | not specified | 2023-02-27 | criteria provided, single submitter | clinical testing | The c.1085T>G (p.L362R) alteration is located in exon 8 (coding exon 8) of the JMJD1C gene. This alteration results from a T to G substitution at nucleotide position 1085, causing the leucine (L) at amino acid position 362 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Breakthrough Genomics, |
RCV004693366 | SCV005190777 | uncertain significance | not provided | criteria provided, single submitter | not provided |